Shu Chuen Li

1.7k total citations
61 papers, 1.2k citations indexed

About

Shu Chuen Li is a scholar working on Economics and Econometrics, Epidemiology and Geriatrics and Gerontology. According to data from OpenAlex, Shu Chuen Li has authored 61 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Economics and Econometrics, 14 papers in Epidemiology and 11 papers in Geriatrics and Gerontology. Recurrent topics in Shu Chuen Li's work include Health Systems, Economic Evaluations, Quality of Life (16 papers), Pharmaceutical Practices and Patient Outcomes (11 papers) and Parkinson's Disease Mechanisms and Treatments (7 papers). Shu Chuen Li is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (16 papers), Pharmaceutical Practices and Patient Outcomes (11 papers) and Parkinson's Disease Mechanisms and Treatments (7 papers). Shu Chuen Li collaborates with scholars based in Australia, Singapore and Vietnam. Shu Chuen Li's co-authors include Hwee Lin Wee, Nan Luo, Surachat Ngorsuraches, David Newby, Julian Thumboo, Louis C.S. Tan, Wing‐Lok Au, Louis Tan, Nan Luo and Wing Lok Au and has published in prestigious journals such as PLoS ONE, Movement Disorders and Vaccine.

In The Last Decade

Shu Chuen Li

60 papers receiving 1.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Shu Chuen Li 302 243 202 179 127 61 1.2k
Ken Lee Chin 174 0.6× 419 1.7× 188 0.9× 246 1.4× 92 0.7× 40 1.6k
Michael R. Kolber 139 0.5× 158 0.7× 207 1.0× 133 0.7× 109 0.9× 92 1.6k
Jane Masoli 315 1.0× 158 0.7× 124 0.6× 110 0.6× 39 0.3× 37 1.2k
Siti Setiati 105 0.3× 257 1.1× 126 0.6× 111 0.6× 231 1.8× 138 1.7k
Chia Siang Kow 321 1.1× 109 0.4× 115 0.6× 85 0.5× 43 0.3× 104 1.4k
Dong Wook Kim 102 0.3× 110 0.5× 219 1.1× 97 0.5× 50 0.4× 92 1.5k
Lise M. Bjerre 88 0.3× 295 1.2× 123 0.6× 314 1.8× 110 0.9× 54 1.4k
Noam Y. Kirson 119 0.4× 127 0.5× 353 1.7× 236 1.3× 112 0.9× 87 1.8k
Celine Sze Ling Chui 259 0.9× 64 0.3× 245 1.2× 130 0.7× 110 0.9× 117 2.1k
Tariq M. Alhawassi 72 0.2× 497 2.0× 235 1.2× 204 1.1× 128 1.0× 61 1.7k

Countries citing papers authored by Shu Chuen Li

Since Specialization
Citations

This map shows the geographic impact of Shu Chuen Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Chuen Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Chuen Li more than expected).

Fields of papers citing papers by Shu Chuen Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu Chuen Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Chuen Li. The network helps show where Shu Chuen Li may publish in the future.

Co-authorship network of co-authors of Shu Chuen Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shu Chuen Li. A scholar is included among the top collaborators of Shu Chuen Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu Chuen Li. Shu Chuen Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hua, Susan, et al.. (2023). Economic burden of advanced lung cancer patients treated by gefitinib alone and combined with chemotherapy in two regions of China. Journal of Medical Economics. 26(1). 1424–1431. 3 indexed citations
2.
Islahudin, Farida, et al.. (2023). Drug-related problems among transfusion-dependent thalassemia patients: A real-world evidence study. Frontiers in Pharmacology. 14. 1128887–1128887. 2 indexed citations
3.
4.
5.
Hương, Nguyễn Thị Liên, et al.. (2019). Impact of pharmaceutical care in the improvement of medication adherence and quality of life for COPD patients in Vietnam. Respiratory Medicine. 153. 31–37. 23 indexed citations
6.
Hương, Nguyễn Thị Liên, et al.. (2018). Effectiveness of a short training program for community pharmacists to improve knowledge and practice of asthma counselling – A simulated patient study. Respiratory Medicine. 144. 50–60. 15 indexed citations
7.
Hure, Alexis, Roseanne Peel, Stephen Hancock, et al.. (2018). Pneumococcal polysaccharide vaccine associated with reduced lengths of stay for cardiovascular events hospital admissions. Vaccine. 36(49). 7520–7524. 2 indexed citations
8.
9.
Kuo, Ho‐Chang, et al.. (2015). Association of Attention deficit hyperactivity disorder and Kawasaki disease: a nationwide population-based cohort study. Epidemiology and Psychiatric Sciences. 25(6). 573–580. 11 indexed citations
10.
11.
12.
Zhou, Hui, Shu Chuen Li, Nasheen Naidoo, Feng Zhu, & Khay Guan Yeoh. (2013). Empirical evidence of the continuing improvement in cost efficiency of an endoscopic surveillance programme for gastric cancer in Singapore from 2004 to 2010. BMC Health Services Research. 13(1). 139–139. 3 indexed citations
13.
Tu, Hong, Robin de Vries, Herman J. Woerdenbag, et al.. (2012). Cost-Effectiveness Analysis of Hepatitis B Immunization in Vietnam: Application of Cost-Effectiveness Affordability Curves in Health Care Decision Making. Value in Health Regional Issues. 1(1). 7–14. 14 indexed citations
14.
Tu, Hong, Herman J. Woerdenbag, Arthorn Riewpaiboon, et al.. (2012). Cost of Illness of Chronic Hepatitis B Infection in Vietnam. Value in Health Regional Issues. 1(1). 23–28. 16 indexed citations
15.
Ong, Siew Chin, Seng Gee Lim, & Shu Chuen Li. (2009). Cultural adaptation and validation of a questionnaire for use in hepatitis B patients. Journal of Viral Hepatitis. 16(4). 272–278. 5 indexed citations
16.
Tan, Louis C.S., et al.. (2008). Factors affecting health‐related quality of life amongst Asian patients with Parkinson’s disease. European Journal of Neurology. 15(7). 737–742. 42 indexed citations
17.
Ong, Siew Chin, Seng Gee Lim, & Shu Chuen Li. (2008). How big is the financial burden of hepatitis B to society? A cost‐of‐illness study of hepatitis B infection in Singapore. Journal of Viral Hepatitis. 16(1). 53–63. 29 indexed citations
18.
19.
Li, Shu Chuen, et al.. (2005). Advice-giving on self-medication: perspectives of community pharmacists and consumers in Singapore. Journal of Clinical Pharmacy and Therapeutics. 30(3). 225–231. 27 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ken Lee Chin Breakdown of academic impact, for papers by Michael R. Kolber Breakdown of academic impact, for papers by Jane Masoli Breakdown of academic impact, for papers by Siti Setiati Breakdown of academic impact, for papers by Chia Siang Kow Breakdown of academic impact, for papers by Dong Wook Kim Breakdown of academic impact, for papers by Lise M. Bjerre Breakdown of academic impact, for papers by Noam Y. Kirson Breakdown of academic impact, for papers by Celine Sze Ling Chui Breakdown of academic impact, for papers by Tariq M. Alhawassi
Rankless by CCL
2026